TherapeuticsMD Inc (TXMD): 32.60% of float is the telling number, 6...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	216
Posts	22621
Boards Moderated	0
Alias Born	10/22/2006

umiak

Re: Paullee post# 360

Monday, 10/16/2017 10:56:43 AM

Monday, October 16, 2017 10:56:43 AM

32.60% of float is the telling number, 67.3m short now. I’m sure it’s happened but I’ve never actually seen a high % short capitulate to buying pressure. They just add more. No idea if move to Nas changes that. Maybe they back off on this dip.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent TXMD News

TherapeuticsMD Announces Full Year 2023 Financial Results • Business Wire • 03/29/2024 08:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 09:51:56 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/06/2023 04:36:35 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/17/2023 02:28:51 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 02:27:23 PM
TherapeuticsMD Announces Third Quarter 2023 Financial Results • Business Wire • 11/14/2023 09:05:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 08:22:58 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 08:20:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 09:18:30 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 11:30:59 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 11:15:28 AM
TherapeuticsMD Announces Second Quarter 2023 Financial Results • Business Wire • 08/14/2023 10:50:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2023 09:29:57 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2023 09:28:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2023 09:27:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 09:20:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/06/2023 08:38:59 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 06/30/2023 12:29:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:21:32 PM
TherapeuticsMD Announces First Quarter 2023 Financial Results • Business Wire • 05/15/2023 08:05:00 PM

More TXMD News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover